logo-large
  • Browse Categories

Publications by authors named "Xing-Dong Lin"

Claim this Profile
D
Discovery of 6-phenylimidazo[2,1-b]thiazole derivatives as a new type of FLT3 inhibitors.
Xing-Dong Lin, Hui-Wen Yang, Shuang Ma, Wei-Wei Li, Chun-Hui Zhang, Lin-Li Li

Bioorg Med Chem Lett· October 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer.
Chun-Hui Zhang, Ming-Wu Zheng, Ya-Ping Li, Xing-Dong Lin, Mei Huang, Wan-Ting Lin

J Med Chem· May 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations.
Jiao Yang, Li-Jiao Wang, Jing-Jing Liu, Lei Zhong, Ren-Lin Zheng, Xing-Dong Lin, Lin-Li Li

J Med Chem· December 2012


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: